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Abstract
Motivation: As the mean age of parenthood grows, the effect of parental age on genetic disease
and child health becomes ever more important. A number of autosomal dominant disorders show
a dramatic paternal age effect due to selfish mutations: substitutions that grant spermatogonial
stem cells (SSCs) a selective advantage in the testes of the father, but have a deleterious effect in
offspring. In this paper we present a computational technique to model the SSC niche in order to
examine the phenomenon and draw conclusions across different genes and disorders.
Results: We used a Markov chain to model the probabilities of mutation and positive selection with
cell divisions. The model was fitted to available data on disease incidence and also mutation
assays of sperm donors. Strength of selective advantage is presented for a range of disorders
including Apert’s syndrome and achondroplasia. Incidence of the diseases was predicted closely
for most disorders and was heavily influenced by the site-specific mutation rate and the number of
mutable alleles. The model also successfully predicted a stronger selective advantage for more
strongly activating gain-of-function mutations within the same gene. Both positive selection and
the rate of copy-error mutations are important in adequately explaining the paternal age effect.
Availability and Implementation: C þþ/R source codes and documentation including compilation
instructions are available under GNU license at https://github.com/anwala/NicheSimulation.
Contact: ewhel001@odu.edu
Supplementary information: Supplementary data are available at Bioinformatics online.

1 Introduction
As the average age of parenthood becomes more delayed, understanding the effect of parental age on child health becomes more important
(Bray et al., 2006). The effect of maternal age has long been acknowledged (Hook, 1981), but in recent years the effect of paternal age has
been the subject of a great deal of study. Paternal age has been linked
to a wide range of traits and diseases, such as spontaneous occurrences
of mutations that cause dominant disorders and X-linked diseases
(Glaser and Jabs, 2004; Risch et al., 1987; Vogel and Rathenberg,
1975). Congenital defects, cancer predisposition disorders, schizophrenia, bipolar disorder, autism and Alzheimer’s disease have also been
linked to father’s age (reviewed in Paul and Robaire, 2013).

Due to the larger number of male germline cell divisions compared
with the female germline, males produce 3–6 times as many mutations
than females throughout evolution (Li et al., 1996). Sperm are produced by a continually dividing population of stem cells and each division represents a chance for replication errors to happen. Penrose
(1955) first proposed that replication errors provided an explanation
for the observed incidence of genetic diseases with paternal age. In
many cases the influence of paternal age is relatively subtle compared
with the large scale chromosomal abnormalities characteristic of
maternal age effect because point mutations typically have small or no
effect on phenotype. However certain substitutions can have devastating effect on those who carry the allele.
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Diseases that show a strong paternal age effect, however, are not
explained purely by Penrose’s copy-error hypothesis and show an
exponential increase in incidence with father’s age. The mutations
responsible typically display a very specific spectrum of missense
substitutions, accumulating faster than the raw mutation rate can
account for. Substitutions associated with these disorders present in
clumps, indicating a positive selective mechanism of mutation accumulation, as opposed to a high mutation rate or ‘hot spot’ model.
Such evidence has so far presented for achondroplasia (Shinde et al.,
2013), Apert’s syndrome (Choi et al., 2008; Qin et al., 2007),
Costello syndrome (Ginnoulatou et al., 2013) and Noonan
Syndrome (Yoon et al., 2013). There is a parallel with the intestinal
crypt where mutant cells colonize their niche through selective advantage conferred by their new phenotype (Bozic and Nowak,
2013). It is also relevant to cancer etiology as paternal age effect mutations are typically found in tumors (Maher et al., 2014).

1.1 The spermatogonial stem cell niche
Spermatogonial stem cells (SSCs) reside on the basal lamina on the outer
edge of the seminiferous tubules within the testes. Spermatogonia are
surrounded by much larger Sertoli cells that form the microenvironment
for the cells. The spermatogonia divide in cyclical waves and progeny of
the stem cells migrate as they divide and differentiate towards the hollow center of the seminiferous tubule (de Rooij and Russell, 2000). In
humans the active SSCs are comprised of type Apale spermatogonia.
Certain stem cell systems like the colonic crypt have specific arrangements of cells with strictly limited numbers of stem cells
(Humphries and Wright, 2008). The SSC niche on the other hand
lacks obvious repeating structures. However, SSCs are observed to
localize to specific areas of the seminiferous epithelium (Yoshida,
2008). While spermatogonia can repopulate whole seminiferous tubules that have been depleted by radiation (Shinohara et al., 2001),
studies of live imaging of stem cells indicate limited migrational
capabilities (Klein et al., 2010). Additionally, cells that migrate
away from the niche are likely to differentiate (de Rooij and van
Beek, 2013), likely because GDNF distribution is patch-like (Sato
et al., 2011), creating effective niche limits.

1.2 Motivation and predictions
The objective of this model was to simulate the accumulation of mutations through positive selection. Several groups have made simulations
of mutation accumulation that can present in the signature arrangement but have been limited to FGFR2 mutations causing Apert’s syndrome (Choi et al., 2008; Qin et al., 2007; Yoon et al., 2009).
Our primary aim was to estimate the r value for a range of disease
causing mutations. Currently the only estimate for an r value comes
from Yoon and colleagues, who estimated it to be 0.014 for Apert’s
syndrome-causing mutations (Yoon et al., 2009). We aim to provide
estimates for a range of different disease causing loci. We hypothesized
that diseases with a more exponential increase with paternal age
would have larger r values. We also aimed to determine if differences
in incidence rate between alleles of a single gene or between mutations
that cause different disorders is due to the underlying mutation rate or
to the selective advantage of the particular alleles. Additionally, where
different mutations affect the same gene, if there is a stronger activating mutation, we expected a higher r value.
The SSC niche has been the subject of some computer simulations of the normal stem cell niche (de Rooij and van Beek, 2013;
Ray et al., 2014) which model the normal homeostasis of the SSC
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niche in terms of spatial arrangement of cell and the cycling of the
seminiferous epithelium. Mutation accumulation by positive selection for Apert syndrome has also been simulated looking purely at
sequence data. Yoon and colleagues were able to simulate mutation
accumulation within the niche to match their mutational data quite
closely. In contrast to the simulation presented in the previous work
for a single syndrome, in this paper we present a mathematical
model that can be used to provide a deeper understanding of mutation accumulation across different genes and disorders.

2 Materials and methods
2.1 Model
We assume that the stem cell niche represents a closed system, with
n cells contained within. Of the n cells, each can be in one of two
states; mutant or wildtype. With each cell division, a stem cell acquires the mutation with probability p. Stem cells are assumed to
divide asymmetrically, one daughter differentiating and ultimately
being lost and the other remaining in the niche. With normal divisions, therefore, the number of stem cells will not change regardless
of divisions. Mutant cells are different from wildtype in that they
have a positive selective probability of r with every cell division, much
higher than the probability of mutation. Should a selection event happen, a mutant cell will divide symmetrically to produce two mutant
cells. This will increase the niche size above the maximum. To correct
this, a random cell is ejected from the niche and lost (all cells are
eligible for ejection, including the newly-formed mutant cell).
The niche, represented by circles, starts with 0 mutant cells out of
n. After a stem cell divides in the niche, the probability p0 indicates
the chance that a mutation occurs and brings the system into state 1
(i.e. one mutant cell in the niche) and q0 that after the cell division
the niche remains in state 0. Once in state 1, the probability of
advancing to state 2 has changed to p1 as the chance of mutation remains but the mutant cells may expand with a selective event.
Correspondingly, the chance that a cell division occurs that maintains
the niche in state 1 is now q1. This continues until, ultimately, all of
the n cells are mutant, at which point the system remains in state n.
We have modeled the system as a Markov chain (Fig. 1). The
chain has n þ 1 states, where state 0 represents the niche comprised
entirely of wildtype cells and in the final state, n, the cells are entirely mutant. Each niche consists entirely of wildtype cells to begin
with and positive selection (r) can only occur once a mutation has
first happened to one of the cells. Cells are selected at random from
the niche to divide sequentially. State i represents the niche with i
mutant cells and ni wildtype cells. In state i there is within the
niche a probability pi that after a cell division the number of mutant
cells will increase by one, and a probability qi that they will remain

Fig. 1. Representation of the probabilities associated with a niche of n stem
cells. The niche, represented by circles, starts with 0 mutant cells out of n.
After a stem cell divides in the niche, the probability p0 indicates the chance
that a mutation occurs and brings the system into state 1 (i.e. one mutant cell
in the niche) and q0 that after the cell division the niche remains in state 0.
Once in state 1, the probability of advancing to state 2 has changed to p1 as
the chance of mutation remains but the mutant cells may expand with a
selective event. Correspondingly, the chance that a cell division occurs that
maintains the niche in state 1 is now q1. This continues until, ultimately, all of
the n cells are mutant, at which point the system remains in state n
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the same. The probability of a mutation and a subsequent reversal at
the same site is sufficiently small as to be ignored.
Let us imagine that the niche is in state i and a random cell is selected to divide. If the cell selected is wildtype, then with probability
p it is transformed into a mutant and returned to the niche, otherwise it is returned as a wildtype. If a mutant cell is selected, it is simply returned to the niche unless a selection event happens with
probability r, in which case two mutant cells are returned and subsequently one random cell is lost (all cells including the returned cells
are eligible to be lost).
In order to calculate qi, the probability that after a cell division
the system remains in state i, there are therefore three mutually exclusive possibilities with the following probabilities:
1. A wildtype cell is selected for division, but no mutation occurs:
ni
ð1  pÞ
n

(2.1)

2. A mutant cell is selected for division and no selection event
happens:
i
ð1  rÞ
n

(2.2)

3. A mutant cell divides, a selection event happens and a mutant
cell is lost from the niche.
i iþ1
r
n nþ1

(2.3)

The combined probability qi is therefore:
qi ¼



i
rðn  iÞ
p
n
nþ1

(2.4)

(2.5)

Since pi ¼ 1  qi, this can be rewritten as:


ni
ir
pi ¼
pþ
n
nþ1

(2.6)

The Markov chain produces a matrix, T, with dimensions of
(n þ 1)  (n þ 1), where rows indicate the starting state and column
denote the final state (i.e. the initial and final number of mutant cells).
3
2
q 0 p0 0 0   
0
0
7
6
6 0 q1 p1 0   
0
0 7
7
6
7
6
6 0 0 q2 p2   
0
0 7
7
6
7
6
7
6 0 0 0 q3   
0
0
(2.7)
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(2.8)

The matrix T was for any given age solved computationally, by
generating a matrix T and calculating values for each cell and then
raising the matrix to the power K. Since the model assumes every individual starts with 0 mutant cells, the only relevant part of the final
solved matrix is the top row.
State 0

1

2

3

...

n1

n

P0

P1

P2

P3

...

Pn1

(2.9)
PS

½

Pn 

For a given state s, the value Ps denotes the probability that starting with 0 mutant cells, after K cell divisions, the niche will have s
mutant cells. The average number of mutants per niche (assuming sufficient number of replications), M, can be calculated by summing all
of the final state values multiplied by the corresponding probabilities.
n
X

sPS

(2.10)

s¼0

With some rearrangement:

0

K ¼ nda
K

M¼

ni
i
i iþ1
ð1  pÞ þ ð1  rÞ þ r
n
n
n nþ1

qi ¼ 1  p þ

two cell divisions within the niche) and TK will provide probabilities for traversing in K steps. In the final matrix, therefore, the
element TijK represents the probability that a niche starting with i
mutant stem cells will end with j mutant stem cells after K cell divisions. Note that K is total cell divisions occurring amongst any of
the cells in the niche, not the average number of divisions per cell,
which would be K/n.
For an individual, the number of steps required, K, is a factor of
the rate of cell division d (divisions per year per cell), the age of the
individual a in years and the number of cells per niche n.

1

This matrix gives the probability of moving from one state to
another in one step i.e. one cell division within the stem cell niche.
The element Tij gives the probability of starting in state i (i.e. a
niche containing i mutant cells) and after one cell division in the
niche ending in state j with j mutant cells. In order to model the
progression of multiple cell divisions within the niche, the matrix
can simply be raised to the power of the number of cell divisions.
T2 will give a matrix that provides probabilities for two steps (i.e.

M/n gives us a single proportion of mutant to wildtype cells at a
given age a. Within an individual person many niches will deviate
dramatically from the average value, but since the number of niches
within a single individual can be assumed to be high (see Section
2.3), but all contribute sperm equally, we can assume that the overall proportion of mutant sperm to wildtype sperm as a whole will
tend towards to M/n.
This can be proven as follows. There are N niches each with n
stem cells. Each niche has a different number of mutant cells, u1, u2,
etc. Each stem cell contributes an equal number of sperm, for simplicity we assume one sperm per stem cell but the following is true for
any value of sperm produced per stem cell division as the proportion
will remain constant.
The total number of mutant cells U is:
U¼

N
X

ui

(2.11)

i¼0

Dividing by the total number of stem cells over all the niches
(Nn) gives the proportion of mutant stem cells over total cells, which
is equivalent to the mean proportion of mutant cells per niche:
U
X
U
¼
n
Nn

(2.12)

 U is the mean number of mutant cells per niche for a
where X
given number of niches N. Taken to the limit:
 
XU
M
¼
lim
(2.13)
N!1
n
n
Therefore using the ideal average value M/n from a single niche
is an accurate measure of mutant sperm proportion for the entire individual providing N is large and all niches contribute sperm equally.
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2.2 Confirmation of model design by simulation
To test the mathematical model, we designed a simulation alongside
it to emulate the progression of a single stem cell niche. Early versions of our simulation were much more complex and attempted to
simulate all the SSCs within an individual, but simulation of a single
niche is sufficient to test the model, particularly averaged over a
large number of repeats (see equation 2.13). Simulation of the stem
cell niche was designed in C þþ. Script design simulated a stem cell
population at a niche level independent of the Markov chain model
(Supplementary Algorithm S1).
The simulation progressed by selecting a random cell. If the selected cell was wildtype it became mutant with probability p and if
the selected cell was mutant it underwent a selective event with
probability r. Selective events represented a symmetric division and
added a mutant cell to the niche. As a consequence a random cell
was then ejected and lost from the niche. This process was repeated
and the simulation was allowed to run for a specific number of cell
divisions sufficient to represent a human reproductive lifespan
(n  d  80 years). The results from each run were then averaged
over a hundred thousand repeats of the simulation.
The simulation was tested against the mathematical expression
by applying equation 2.10 with the same parameters and age values
as the simulation. The simulation tended towards the values provided by the model and showed perfect agreement with sufficient
replication (Supplementary Fig. S1).

2.3 Parameters
2.3.1 Mutation probability, p
Rahbari et al. (2016) estimated the mutation frequency per nucleotide per germline cell division at 4  1011 calculated by sequencing
multi-sibling families. This mutation rate is close to that calculated
with phylogenetic data (Lynch, 2010) and point mutations on the Ychromosome (Helgason et al., 2015). Rahbari and colleagues also
noted little variation of mutation rate with paternal age, which
allowed us to assume p is a constant value regardless of age. This is
the baseline mutation probability per site, before accounting for elevated mutational frequency due to CpG sites or multiple diseasecausing alleles within a single gene.
2.3.2 Stem cells per niche, n
SSCs are not organized in regular repeating structures with defined
cell numbers like the colonic crypt (Humphries and Wright, 2008)
and this makes estimating the niche size difficult. While initial models of the SSC niche did not have discrete compartmentalization, recent research has shown preferential clustering of SSCs to specific
regions of the seminiferous basal lamina (de Rooij and Griswold,
2012; Yoshida et al., 2007). To estimate the number of SSCs per
niche, we turned to studies in mice, where spermatogenesis has been
reconstituted in sterile mice by transplantation of SSCs bearing a reporter gene. From Shinohara et al. (2001), adult mice generated at
least 108 colonies per testis. Given 35 000 stem cells per mouse testis
(Tegelenbosch and de Rooij, 1993), this amounts to 324 stem cells
per niche. Scaling up to human testes by weight, assuming the same
number of stem cells per niche, gives us approximately 3 million individual niches, which fulfills the requirement of equation 2.13. The
model also assumes the number of SSCs remains constant throughout life. In reality, the number of stem cells declines with age
(Paul & Robaire, 2013). Assuming attrition occurs evenly among
mutant and wildtype stem cells, this stochastic loss will not affect
the proportion of mutant to wildtype sperm over many niches. The
caveat to this is that it is possible that the mutant cells, rather than a
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proliferative advantage, are granted some form of resistance to the
age-based attrition. Finally, as hypothesized by Yoon et al. (2009),
non-proliferating Adark spermatogonia may activate as reserve stem
cells and replace losses (including lost mutant cells) with wildtype
cells. This would cause a ‘dip’ in the mutation frequency, irrespective of gene as fresh wildtype cells are introduced into the system.
This would be informative to model across disorders but is beyond
the scope of this paper.

2.3.3 Stem cell divisions per year, d
Human spermatogenesis results in one stem cell divisions per spermatogenic cycle of the Apale spermatogonia, so once every 16 days
(de Rooij and Russell, 2000), although lower estimates exist
(Tomasetti and Vogelstein, 2015). The model selects cells to divide
randomly rather than in waves, however the odds of the same cell
being selected repeatedly is low and the results are averaged over a
large number of niches, the effect of this is negligible and allows us
to avoid tracking individual cells.

2.3.4 Selection pressure, r
This is the probability that when a pre-existing mutant cell divides it
will do so symmetrically and self-renew. The model fits a best-fit
curve for the optimal r value to fit the data. Note that in normal
steady-state division, SSCs may divide symmetrically into Apaired
spermatogonia where both daughter cells remain stem cells or both
differentiate (de Rooij and Griswold, 2012) for which there is some
evidence (Klein et al., 2010). For simplicity we have assumed, as earlier models have done (Yoon et al., 2009), that each stem cell divides
asymmetrically in normal homeostatic cell division rather than a
balance of differentiating and self-renewing divisions.

2.4 Fitting the model to mutation data
In order to match our model to existing paternal age effect data, we
started with birth incidence of various genetic diseases. The larger
number of younger parents versus older ones is accounted for by
looking at Observed/Expected values, the number of births for a
given age category divided by the expected number of births assuming the total number of disease-affected children were distributed to
each age category proportional to births in that population.
Using census data from 1966 USA birth data (Vital Statistics of
the United States, 1966, U.S. Department of Health, Education and
Welfare) to estimate a number of births per age category, Ca, (as per
Risch et al., 1987), we used the M/n fraction of mutant-to-wildtype
sperm for the given age category to produce a number of diseaseaffected births for that category, simulated mutant births (S).
S¼

M
Ca
n

(3.1)

By dividing the number of fathers in the age category by the total
population and then multiplying this proportion by the total number
of simulated mutant births, we can calculate the predicted mutant
births (P) assuming simulated mutant births are distributed proportional to the paternal age distribution.
P¼

Ca X
S
Ct

(3.2)

Simulated/Predicted is therefore directly comparable to the
Observed/Expected data. In order to fit the S/P data to the existing
O/E values, the strength of selection, r, had to be empirically determined. A script was generated in R (R Development Core Team,
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2008, URL http://www.R-project.org.) that would match the O/E
values according to the following algorithm:
1. For a given value of r, calculate a single S/P value for the median
age of the following age categories: 20–24, 25–29, 30–34, 35–
39, 40–44, 45–49, 50–54. In each case the average age for the
category was used to generate the S/P value.
2. Calculate the difference between each S/P value and the corresponding O/E value. Take the sum of squares (SOS) of these differences.
3. The process was optimized for r using R’s optim function by
searching for the r value with the lowest SOS score.

3 Results
Figure 2 shows the matched model and disease data graphs for eight
disorders that show a strong paternal age effect. Excluding FOP as
an outlier (see Section 4), the remaining predicted incidence values
correlated significantly with the actual incidence values (Pearson’s
correlation coefficient ¼ 0.91, p < 0.05). With those disorders where
sequence data is available (Costello, Apert and thanatophoric dysplasia syndromes), r values can be compared directly between disease data and sperm mutation rates and show close agreement
(TOST equivalence test, e ¼ 0.0053, p < 0.05). The probabilities of
positive selection varied from 0.5 to 1.5% with a mean r value of
0.0083 for r values from birth data and 0.0094 from sequence data.
The predicted incidence rate is shown in Table 2. The raw incidence assumes the baseline mutation rate p of 4  1011. However,
mutation rate varies by location in the genome and the sequence in
question and of particular interest are CpG sites. These are particularly
mutable as cytosine in CpG sites is a methylation site and can spontaneously deaminate to thymine (Lynch, 2010). In order to account for
the increased mutation chance, the probability of CpG-specific alleles
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mutating was multiplied by a factor of 15 for a transition or 5 for a
transversion (Nachman and Crowell, 2000). Additionally, a number
of paternal age effect disorders are caused by multiple mutations at a
variety of loci and by looking at disease incidence of the disorder as a
metric, we include all mutations that contribute to that disease phenotype. In order to simulate this in the model, the aggregate probability
of mutation, pa, is the probability of any of the mutations occurring
that give rise to the phenotype, with the formula:
pa ¼ 1  ðð1  pÞa Þ

(3.3)

where p is the baseline mutation probability and a is the number of
potential mutation sites that can produce mutant alleles.

4 Discussion
We hypothesized that one of the two Apert’s syndrome-causing mutations (C755G) has a higher incidence than the other (C758G) because
the former occurs at a CpG dinucleotide, which has a higher mutability due to spontaneous deamination. Our results support this hypothesis as both of the Apert mutations have a very similar r value with
0.0124 for C755G compared with 0.0126 for C758G (see Table 1).

Table 1. Strength of positive selection (r) for eight diseases
Gene

r value
(sequencing data)a

r value
(birth data)b

Achondroplasia
Apert’s syndrome

FGFR3
FGFR2

0.00741
0.00888

Costello syndrome
Crouzon syndrome
FOP
Marfan syndrome
Pfeiffer syndrome
Thanatophoric dysplasia

HRAS
FGFR2
ACVR1
FBN1
FGFR2
FGFR3

—c
(C755G) 0.0124
(C758G) 0.0126
(G34A) 0.00526
—
—
—
—
(A1948G) 0.0105

Disease

0.00606
0.00997
0.0135
0.00517
0.00668
0.00937

FOP, fibrodysplasia ossificans progressiva.
a
Calculated by directly matching mutation incidence to that from sperm
DNA sequencing (see Fig. 3), specific mutation is shown in parentheses.
b
Calculated from birth incidence rates by making the best fit of O/E curves,
with adjusted mutation rates (see Fig. 2).
c
Several studies have estimated the mutation rate of achondroplasia in
sperm but have been omitted due to concerns of the methodology (Maher
et al., 2014).

These two distinct amino-acid substitutions (S252W and P253R) appear therefore to have the same selective effect on the cell and the
increased incidence of S252W is purely because of increased mutability at this site. The projected incidence rate is very sensitive to the
model parameters and particularly the mutation rate. For example,
achondroplasia has a high incidence rate relative to the other diseases
(1 in 27 000, see Table 2). The computed r value on the other hand
was middle of the range (see Table 1), which failed to account for the
high incidence rate when the baseline value for p was used. Once the
value of p was increased to the level of a C!T transition, the predicted incidence agreed well. So the site-specific mutation rate accounted for the relatively high incidence rate of this disease.
Apert syndrome (Yoon et al., 2009), Costello syndrome
(Giannoulatou et al., 2013) and Thanatophoric dysplasia (TD)
adapted from Goriely et al. (2009).
The predicted incidence rates, after accounting for the number of
alleles and the mutation rate, present close to the actual values, with
the exception of fibrodysplasia ossificans progressiva. This disease is
anomalous as it is a very rare disease (one in 2 million births) but it is
predicted to have a high incidence rate as it is caused by a transition
at a single CpG site (Shore et al., 2006). While the rates of substitution vary by location in the genome, including the rates at CpG sites
(Fryxell and Moon, 2005; Mugal and Ellegren, 2011), it is unlikely
the substitution rate could be low enough at this point, even if unmethylated. It might be explained by a very low selective advantage but
the projected r value is high (0.0135), producing an O/E curve similar to achondroplasia. The low birth prevalence is also not explained
by low survival to term of affected offspring as FOP does not show
severe symptoms until later in life or by any variation of expression
of the mutant allele as it shows complete penetrance (Petrie et al.,
2009) so the low incidence rate remains unexplained.
The mutations causing thanatophoric dysplasia and achondroplasia both cause constitutive activation of the FGFR3 but TD mutations activate the receptor more strongly, leading to a more severe
phenotype (Naski et al., 1996; Bonaventure et al., 2007). We can
therefore predict the r value for TD to be higher than that for achondroplasia, which is confirmed by our model (TD r ¼ 0.0105, achondroplasia r ¼ 0.00741). Note that both sets of data were taken from
one study (Orioli et al., 1995) in order to ensure that they are
comparable.
Our estimate for r from sequence data for Apert’s syndrome
(r ¼ 0.0125) showed good agreement with that estimated by Yoon
and colleagues, who estimated r to be 0.014 (Yoon et al., 2009),
although the value from birth data was lower (r ¼ 0.00888).

Table 2. Incidence rates of eight diseases
Disease

Raw predicted
incidence rate

Adjusted predicted
incidence rate

Literature
incidence rate

References and sources

Alleles

ACH
Apert
Costello
Crouzon
FOP
Marfan
Pfeiffer
Thanatophoric dysplasia

1 in 400 000
1 in 700 000
1 in 2 300 000
1 in 600 000
1 in 340 000
1 in 3 400 000
1 in 1 600 000
1 in 720 000

1 in 27 000
1 in 130 000
1 in 160 000
1 in 37 000
1 in 23 000
1 in 68 000
1 in 130 000
1 in 60 000

1 in 26 000
1 in 100 000
1 in 300 000
1 in 60 000
1 in 2 000 000
1 in 70 000
1 in 100 000
1 in 40 000

Faruqi et al. (2014)
Blank (1960)
Lurie (1994)
Helman et al. (2014)
Hüning and Gillessen-Kaesbach (2014)
Lynas (1958)
Vogels and Fryns (2006)
Connor et al. (1985)

1
2
14
16
1
50
12
12

ACH, achondroplasia; FOP, fibrodysplasia ossificans progressiva.
Raw predicted incidence rates calculated with a baseline mutation rate of 4 1011. Adjusted rates account for variation in mutation rate at CpG dinucleotides
and the number of mutable alleles that cause the disease phenotype. Alleles denote the number of most common genetic variants that comprise at least 95% of
cases of the disease (Online Mendelian Inheritance in Man, 2016). Incidence rates of ACH is a mean value between 0.36 and 0.6 per 10 000 after accounting for
20% of ACH cases being inherited from an affected parent.
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The model presented in this paper provides a mathematical
understanding of the accumulation of selfish disease-causing mutations. We have successfully predicted the incidence rates of different
diseases based on O/E curves and information of the molecular nature of the mutations and estimates for the strength of selection. The
selective advantage granted by these mutations is the most important factor in terms of the exponential increase over time but the sitespecific mutation rate and the number of mutable sites plays a key
role in how common the disease is at the population level.
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